Academic Journal

Animal models in leukotriene research: Current insights into complex pathways and therapeutic intervention.

Bibliographic Details
Title: Animal models in leukotriene research: Current insights into complex pathways and therapeutic intervention.
Authors: Teder T; Division of Physiological Chemistry II, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Rådmark O; Division of Physiological Chemistry II, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Haeggström JZ; Division of Physiological Chemistry II, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Lõhelaid H; Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Finland. Electronic address: helike.lohelaid@helsinki.fi.
Source: Pharmacology & therapeutics [Pharmacol Ther] 2025 Dec; Vol. 276, pp. 108944. Date of Electronic Publication: 2025 Oct 27.
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
Language: English
Journal Info: Publisher: Pergamon Press Country of Publication: England NLM ID: 7905840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-016X (Electronic) Linking ISSN: 01637258 NLM ISO Abbreviation: Pharmacol Ther Subsets: MEDLINE
Imprint Name(s): Original Publication: Oxford, Elmsford, N. Y., Pergamon Press.
MeSH Terms: Leukotrienes*/metabolism , Models, Animal*, Arachidonate 5-Lipoxygenase/metabolism ; Oxylipins/metabolism ; Animals ; Humans ; Disease Models, Animal
Abstract: Oxylipins are oxygenated bioactive lipid mediators formed from different polyunsaturated fatty acids through the bioactions of cyclooxygenases, lipoxygenases and cytochrome P450 enzymes, and participate in many physiological and pathophysiological processes. For example, oxylipins regulate vascular tone, the onset of labor, pain, inflammation, fever and contribute to diseases such as asthma, cancer, arthritis, diabetes, obesity and neurodegenerative disorders. Understanding the mechanisms and cellular components involved in oxylipin biosynthesis is crucial for developing effective therapies that minimize complications and improve disease outcomes. Thus far, various animal models have increased our understanding of oxylipin biosynthesis and regulation in complex biological environments. These models have also facilitated the discovery of novel drug targets and the evaluation of drug safety and efficacy. However, each species used as a model system has its own advantages and limitations. Here we provide an overview of the most relevant and widely used models in lipid mediator research with a focus on 5-lipoxygenase and leukotriene pathway, emphasizing the significance of animal models in advancing our understanding of the complexities of leukotriene biology and its implications for human health.
(Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.)
Competing Interests: Declaration of competing interest No competing interest.
Contributed Indexing: Keywords: 5-Lipoxygenase; Animal models; Disease mechanisms; Inflammation; Leukotrienes; Oxylipins
Substance Nomenclature: 0 (Leukotrienes)
EC 1.13.11.34 (Arachidonate 5-Lipoxygenase)
0 (Oxylipins)
Entry Date(s): Date Created: 20251029 Date Completed: 20251112 Latest Revision: 20260610
Update Code: 20260610
DOI: 10.1016/j.pharmthera.2025.108944
PMID: 41161355
Database: MEDLINE
FullText Text:
  Availability: 0
CustomLinks:
  – Url: https://www.doi.org/10.1016/j.pharmthera.2025.108944?
    Name: ScienceDirect (all content) (s7799221)
    Category: fullText
    Text: View record from ScienceDirect
    MouseOverText: View record from ScienceDirect
  – Url: https://resolver.ebsco.com/c/fiv2js/result?sid=EBSCO:cmedm&genre=article&issn=1879016X&ISBN=&volume=276&issue=&date=20251201&spage=108944&pages=108944&title=Pharmacology & therapeutics&atitle=Animal%20models%20in%20leukotriene%20research%3A%20Current%20insights%20into%20complex%20pathways%20and%20therapeutic%20intervention.&aulast=Teder%20T&id=DOI:10.1016/j.pharmthera.2025.108944
    Name: Full Text Finder (for New FTF UI) (ns324271)
    Category: fullText
    Text: Full Text Finder
    MouseOverText: Full Text Finder
Header DbId: cmedm
DbLabel: MEDLINE
An: 41161355
AccessLevel: 3
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Animal models in leukotriene research: Current insights into complex pathways and therapeutic intervention.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Teder+T%22">Teder T</searchLink>; Division of Physiological Chemistry II, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Rådmark+O%22">Rådmark O</searchLink>; Division of Physiological Chemistry II, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Haeggström+JZ%22">Haeggström JZ</searchLink>; Division of Physiological Chemistry II, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Lõhelaid+H%22">Lõhelaid H</searchLink>; Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Finland. Electronic address: helike.lohelaid@helsinki.fi.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227905840%22">Pharmacology & therapeutics</searchLink> [Pharmacol Ther] 2025 Dec; Vol. 276, pp. 108944. <i>Date of Electronic Publication: </i>2025 Oct 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review; Research Support, Non-U.S. Gov't
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Pergamon+Press%22">Pergamon Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7905840 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-016X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201637258%22">01637258 </searchLink><i>NLM ISO Abbreviation: </i>Pharmacol Ther <i>Subsets: </i>MEDLINE
– Name: PublisherInfo
  Label: Imprint Name(s)
  Group: PubInfo
  Data: <i>Original Publication</i>: Oxford, Elmsford, N. Y., Pergamon Press.
– Name: SubjectMESH
  Label: MeSH Terms
  Group: Su
  Data: <searchLink fieldCode="MM" term="%22Leukotrienes%22">Leukotrienes*</searchLink>/<searchLink fieldCode="MM" term="%22Leukotrienes+metabolism%22">metabolism</searchLink> <br /><searchLink fieldCode="MM" term="%22Models%2C+Animal%22">Models, Animal*</searchLink><br /><searchLink fieldCode="MH" term="%22Arachidonate+5-Lipoxygenase%22">Arachidonate 5-Lipoxygenase</searchLink>/<searchLink fieldCode="MH" term="%22Arachidonate+5-Lipoxygenase+metabolism%22">metabolism</searchLink> ; <searchLink fieldCode="MH" term="%22Oxylipins%22">Oxylipins</searchLink>/<searchLink fieldCode="MH" term="%22Oxylipins+metabolism%22">metabolism</searchLink> ; <searchLink fieldCode="MH" term="%22Animals%22">Animals</searchLink> ; <searchLink fieldCode="MH" term="%22Humans%22">Humans</searchLink> ; <searchLink fieldCode="MH" term="%22Disease+Models%2C+Animal%22">Disease Models, Animal</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Oxylipins are oxygenated bioactive lipid mediators formed from different polyunsaturated fatty acids through the bioactions of cyclooxygenases, lipoxygenases and cytochrome P450 enzymes, and participate in many physiological and pathophysiological processes. For example, oxylipins regulate vascular tone, the onset of labor, pain, inflammation, fever and contribute to diseases such as asthma, cancer, arthritis, diabetes, obesity and neurodegenerative disorders. Understanding the mechanisms and cellular components involved in oxylipin biosynthesis is crucial for developing effective therapies that minimize complications and improve disease outcomes. Thus far, various animal models have increased our understanding of oxylipin biosynthesis and regulation in complex biological environments. These models have also facilitated the discovery of novel drug targets and the evaluation of drug safety and efficacy. However, each species used as a model system has its own advantages and limitations. Here we provide an overview of the most relevant and widely used models in lipid mediator research with a focus on 5-lipoxygenase and leukotriene pathway, emphasizing the significance of animal models in advancing our understanding of the complexities of leukotriene biology and its implications for human health.<br /> (Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.)
– Name: Abstract
  Label: Competing Interests
  Group: Ab
  Data: Declaration of competing interest No competing interest.
– Name: SubjectMinor
  Label: Contributed Indexing
  Group:
  Data: <i>Keywords: </i>5-Lipoxygenase; Animal models; Disease mechanisms; Inflammation; Leukotrienes; Oxylipins
– Name: NumberCAS
  Label: Substance Nomenclature
  Group: ID
  Data: 0 (Leukotrienes)<br />EC 1.13.11.34 (Arachidonate 5-Lipoxygenase)<br />0 (Oxylipins)
– Name: DateEntry
  Label: Entry Date(s)
  Group: Date
  Data: <i>Date Created: </i>20251029 <i>Date Completed: </i>20251112 <i>Latest Revision: </i>20260610
– Name: DateUpdate
  Label: Update Code
  Group: Date
  Data: 20260610
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.1016/j.pharmthera.2025.108944
– Name: AN
  Label: PMID
  Group: ID
  Data: 41161355
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=cmedm&AN=41161355
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.pharmthera.2025.108944
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 108944
    Subjects:
      – SubjectFull: Arachidonate 5-Lipoxygenase metabolism
        Type: general
      – SubjectFull: Oxylipins metabolism
        Type: general
      – SubjectFull: Animals
        Type: general
      – SubjectFull: Humans
        Type: general
      – SubjectFull: Disease Models, Animal
        Type: general
      – SubjectFull: Leukotrienes metabolism
        Type: general
      – SubjectFull: Models, Animal
        Type: general
    Titles:
      – TitleFull: Animal models in leukotriene research: Current insights into complex pathways and therapeutic intervention.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Teder T
      – PersonEntity:
          Name:
            NameFull: Rådmark O
      – PersonEntity:
          Name:
            NameFull: Haeggström JZ
      – PersonEntity:
          Name:
            NameFull: Lõhelaid H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2025 Dec
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1879-016X
          Numbering:
            – Type: volume
              Value: 276
          Titles:
            – TitleFull: Pharmacology & therapeutics
              Type: main
ResultId 1